Shared on06 Aug 25Fair value Decreased 9.19%
The consensus price target for OPKO Health has been reduced, primarily reflecting lower revenue growth expectations and a higher discount rate, resulting in a new fair value estimate of $3.62. What's in the News Issued 2025 revenue guidance of $640–$660 million.
Shared on24 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on17 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on09 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on02 Apr 25Fair value Decreased 18%
AnalystConsensusTarget has decreased revenue growth from 6.0% to 4.9%, decreased future PE multiple from 123.3x to 76.6x and decreased shares outstanding growth rate from 0.1% to -0.0%.